FDA psychiatry product division director joins Allergan

Following a 12-year tenure as director of FDA’s Division of Psychiatry Products, Mitchell Mathis has joined Allergan plc (NYSE:AGN) as CMO for CNS products.

Mathis left FDA on Jan. 19 and joined Allergan later in the month. ...